![glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination](https://www.preprints.org/frontend/picture/ms_xml/manuscript/28233dba55c7b404c1a8e0b10dd5de8e/preprints-107031-g002.png)
glp 1 mimetic
Shipping Estimate
glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination
USD23.29
USD45.29
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
![glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination](https://cached.imagescaler.hbpl.co.uk/resize/scaleWidth/952/cached.offlinehbpl.hbpl.co.uk/news/2MM/Xultophy-insulin-degludec-liraglutide-type-II-diabetes-GLP-1-agonist-incretin-mimetic-DUAL-I-DUAL-II-metformin-20141210042145270.jpg)
![glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination](https://ars.els-cdn.com/content/image/1-s2.0-S2212877820301769-gr6.jpg)
![glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination](https://www.cell.com/cms/10.1016/j.cmet.2025.10.014/asset/fb73a5bb-243a-4770-bdc1-8f9ade3982d2/main.assets/fx1_lrg.jpg)
![glp 1 mimetic A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Xutolphy: first insulin/GLP-1 analogue combination](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-024-02300-6/MediaObjects/592_2024_2300_Fig1_HTML.png)
